Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

FDA Requests Removal of Opana ER for Risks Related to Abuse

June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking remo

FDA Approves Two-Month Aristada for Treatment of Schizophrenia

DUBLIN--(BUSINESS WIRE)--Jun. 6, 2017-- Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizo

Childhood Cancer Survivors Now Living Healthier Lives

FRIDAY, June 2, 2017 -- For people who battled cancer in childhood, the prospects for a long life without cancer recurrence or chronic illness are better than ever, a new study finds.Thats largely due to changes in cancer treatment protocols that have

What You Need to Know About Antidepressants

FRIDAY, June 2, 2017 -- Medication can help millions of people who struggle with depression, according to the U.S. Food and Drug Administration.Depression affects some 350 million people worldwide. Its a serious illness and a major cause of disability

Health Highlights

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:Heart Pump Controllers RecalledNearly 29,000 controllers for implanted heart pumps are being recalled after reports of malfunctions resulting in

FDA Approves Kevzara

FDA Approves KevzaraSanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Dr